We have generated a mouse knockout (KO) of the regulator of G protein signaling 14 (RGS14). The RGS14 KO mice live longer than their wild type (WT) littermates and are protected against stress, type 2 diabetes and obesity, all features related to cardiovascular risk protection. The mechanisms mediating these salutary effects of the RGS14 KO involve the striated muscle. The RGS14 KO also has increased brown adipose tissue, which is likely involved in the mechanism of its protective effects. The goal of this proposal is to determine the mechanisms mediating these salutary actions. We plan to establish the RGS14 KO as a novel model for longevity and determine to what extent striated muscle specific loss of RGS 14 and brown adipose tissue contribute to longevity, and protection against obesity and diabetes. In this proposal ?diabetes? is used to reflect protection of glucose utilization and insulin resistance, rather than the clinical disease. Our long term goal is to develop a clinically useful pharmacological inhibitor of RGS14. The proposal is based on the following hypotheses: Hypothesis A: Striated muscle specificity of RGS14 KO protects against the development of insulin resistance, glucose intolerance and obesity and extends lifespan mediated by increased energy metabolism through mitochondrial oxidation and protection against oxidative stress through the NAD+/SIRT3/MnSOD pathway. Hypothesis B: The RGS14 KO has the additional novel feature of increased brown adipose tissue, which also protects against diabetes, obesity and prolongs lifespan.
The rapidly growing population of aging patients with diabetes and obesity, major factors contributing to cardiac disease and death, constitutes a problem of epidemic proportions in the US, with corresponding health care costs that result in increased debt for our country. The critical barrier to progress in the field is a lack of novel models to increase longevity, and more importantly to protect cardiovascular risk, by protecting against diabetes, and obesity in the aging population. Although diet can improve the health of aging patients with diabetes, obesity and heart disease, patient compliance becomes an issue. It would be far better to have a new drug, which might accomplish the same ends through more palatable means. The RGS14 knockout (KO) provides such an opportunity, since it is a model for longevity, and also protects against diabetes and obesity and has increased brown adipose tissue (BAT).
| Zhao, Zhenghang; Kudej, Raymond K; Wen, Hairuo et al. (2018) Antioxidant defense and protection against cardiac arrhythmias: lessons from a mammalian hibernator (the woodchuck). FASEB J 32:4229-4240 |
| Zhang, Jie; Levy, Daniel; Oydanich, Marko et al. (2018) A novel adenylyl cyclase type 5 inhibitor that reduces myocardial infarct size even when administered after coronary artery reperfusion. J Mol Cell Cardiol 121:13-15 |
| Vatner, Dorothy E; Zhang, Jie; Oydanich, Marko et al. (2018) Enhanced longevity and metabolism by brown adipose tissue with disruption of the regulator of G protein signaling 14. Aging Cell :e12751 |
| Guers, John J; Zhang, Jie; Campbell, Sara C et al. (2017) Disruption of adenylyl cyclase type 5 mimics exercise training. Basic Res Cardiol 112:59 |
